|
In the next few days, we'll present a detailed report on the convention that was recently held in Rome. Eurosalus had an active role in the organization of the convention and the importance and the innovative nature of the talks that were given confirmed the soundness of our undertaking.
Professor Biava spoke in detail of the innovative therapeutic procedures used in cancer therapy and their conceptual simplicity. Reeducating the cell instead of “eliminating it with a bazooka”, represents an enormous conceptual innovation that leads the disease back to being a regulatory disturbance rather than a cell gone completely out-of-control.
Biava's public presentation, clear and understandable as always, of the study in Oncology Research on the abdominal CAT scans of patients fascinated the audience. The complete disappearance of multiple hepatocellular carcinoma nodules (liver tumor) in people who began treatment in conditions that were defined as irreversible is incredible and riveting news for a doctor. Even the considerable number of people in the audience who weren't medical professionals were impressed by the evidence provided by the x-rays that were shown.
The work undertaken by Biava was performed on cases of patients deemed to be incurable and destined to die within a few weeks or months. The acknowledgment that over 20% of these cases were completely cured and that in 12-14% of the cases the disease's evolution was blocked signified that one third of the patients survived beyond anyone's expectations.
This is a therapy that can be perfected and improved. It can especially become more personalized and the coming years will lead to new developments in cancer therapy that are unconceivable today.
What's interesting is the silence on the part of the establishment and it represents the most negative aspect in this environment. In the presence of a therapy that is actually of a nutritional type (regulating factors can be funneled into the body in a sublingual fashion and the product (which is already available in Italy) is a food protein and therefore is classified as a nutraceutical. It's surprising that it still hasn't been utilized and experimented by many centers.
In the afternoon, Pier Mario Biava and Attilio Speciani took the floor. They spoke of the therapy in practical terms: dosages, length of treatment and application possibilities. They emphasized the importance of choosing a nutritional regime that regulates hormones and inflammation (like the GIFT Diet which controls against the development of inflammatory adipokines and improves insulin sensitivity). In addition to this, they explained how the use of food supplements that are active on nuclear factors such as NF-kB (Turmeric, Resveratrol, Zinc, Copper) represented an ideal complement because they enhanced the balancing action of this type of therapy in an optimal way.
|